These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 23406724)
1. Are biomarkers still helpful in hepatocellular carcinoma? Lamerz R Digestion; 2013; 87(2):118-20. PubMed ID: 23406724 [No Abstract] [Full Text] [Related]
2. Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma. Li X; Wu K; Fan D Hepatology; 2009 Nov; 50(5):1682. PubMed ID: 19739256 [No Abstract] [Full Text] [Related]
3. [Alpha-fetoprotein and its fucosylation index in the early diagnosis of hepatocellular carcinoma]. Aoyagi Y; Mita Y; Kuroiwa T; Wakuri N; Kawai H; Kobayashi M; Igarashi M; Suda T Nihon Rinsho; 2001 Oct; 59 Suppl 6():342-8. PubMed ID: 11761969 [No Abstract] [Full Text] [Related]
4. [The role of tumor markers in the diagnosis and follow-up of liver tumors]. Ottó S Orv Hetil; 2004 Feb; 145(7 Suppl 1):385-7. PubMed ID: 15049057 [TBL] [Abstract][Full Text] [Related]
5. [Molecular markers for early diagnosis of hepatocellular carcinoma]. Yao DF Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213 [No Abstract] [Full Text] [Related]
6. Circulating microRNAs as biomarkers for hepatocellular carcinoma. Qu KZ; Zhang K; Li H; Afdhal NH; Albitar M J Clin Gastroenterol; 2011 Apr; 45(4):355-60. PubMed ID: 21278583 [TBL] [Abstract][Full Text] [Related]
7. Screening for hepatocellular carcinoma. Haydon GH; Hayes PC Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):856-60. PubMed ID: 8889450 [TBL] [Abstract][Full Text] [Related]
8. [The application of serum tumor markers in the diagnosis of hepatocellular carcinoma]. Liao HY Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):379-80. PubMed ID: 15918977 [No Abstract] [Full Text] [Related]
9. [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma]. Aoyagi Y; Suda T; Kawai H; Tamura Y; Igarashi M Nihon Rinsho; 2010 Jul; 68 Suppl 7():665-9. PubMed ID: 20960847 [No Abstract] [Full Text] [Related]
10. New frontiers in biomarkers for hepatocellular carcinoma. Giannelli G; Antonaci S Dig Liver Dis; 2006 Nov; 38(11):854-9. PubMed ID: 16782417 [TBL] [Abstract][Full Text] [Related]
11. Alpha-fetoprotein and hepatocellular carcinoma. Colli A; Fraquelli M; Conte D Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257 [No Abstract] [Full Text] [Related]
12. [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma]. Aoyagi Y; Kubota T Nihon Rinsho; 2005 Aug; 63 Suppl 8():625-8. PubMed ID: 16149595 [No Abstract] [Full Text] [Related]
13. [Nonspecific tumor markers in hepatocellular carcinoma]. Stanciu L; Dumitraşcu D; Radu D; Badea R; Petcovici M; Ioniţă A; Szabo P; Pascu O Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(5):443-9. PubMed ID: 2473509 [No Abstract] [Full Text] [Related]